These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10886222)

  • 1. Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma.
    Hornsey VS; Krailadsiri P; MacDonald S; Seghatchian J; Williamson LM; Prowse CV
    Br J Haematol; 2000 Jun; 109(3):665-70. PubMed ID: 10886222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants.
    Aznar JA; Bonanad S; Montoro JM; Hurtado C; Cid AR; Soler MA; De Miguel A
    Vox Sang; 2000; 79(3):156-60. PubMed ID: 11111234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryoprecipitate prepared from plasma treated with methylene blue plus light: increasing the fibrinogen concentration.
    Hornsey VS; Young DA; Docherty A; Hughes W; Prowse CV
    Transfus Med; 2004 Oct; 14(5):369-74. PubMed ID: 15500456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems.
    Burnouf T; Caron C; Radosevich M; Goubran HA; Goudemand J; El-Ekiaby M
    Haemophilia; 2008 Sep; 14(5):956-62. PubMed ID: 18565126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative and qualitative analysis of coagulation factors in cryoprecipitate prepared from fresh-frozen plasma inactivated with amotosalen and ultraviolet A light.
    Cid J; Caballo C; Pino M; Galan AM; Martínez N; Escolar G; Diaz-Ricart M
    Transfusion; 2013 Mar; 53(3):600-5. PubMed ID: 22738354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paired comparison of methylene blue- and amotosalen-treated plasma and cryoprecipitate.
    Backholer L; Wiltshire M; Proffitt S; Cookson P; Cardigan R
    Vox Sang; 2016 May; 110(4):352-61. PubMed ID: 26757252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VIII/von Willebrand factor complex in methylene blue-treated fresh plasma.
    Aznar JA; Molina R; Montoro JM
    Transfusion; 1999 Jul; 39(7):748-50. PubMed ID: 10413283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
    Mazurier C; Samor B; Deromeuf C; Goudemand M
    Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
    Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
    Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of canine donor plasma hemostatic protein concentration on quality of cryoprecipitate.
    Drinkhouse M; Brooks MB; Stefanovski D; Marryott K; Callan MB
    J Vet Intern Med; 2019 Jan; 33(1):124-131. PubMed ID: 30548342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's happening? The quality of methylene blue treated FFP and cryo.
    Seghatchian J; Krailadsiri P
    Transfus Apher Sci; 2001 Dec; 25(3):227-31. PubMed ID: 11846153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing.
    Lokhandwala PM; O'Neal A; Patel EU; Brunker PAR; Gehrie EA; Zheng G; Kickler TS; Ness PM; Tobian AAR
    Transfusion; 2018 May; 58(5):1126-1131. PubMed ID: 29479708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women.
    Tanaka KA; Bharadwaj S; Hasan S; Judd M; Abuelkasem E; Henderson RA; Chow JH; Williams B; Mazzeffi MA; Crimmins SD; Malinow AM
    Br J Anaesth; 2019 Jun; 122(6):751-759. PubMed ID: 30916034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending the post-thaw viability of cryoprecipitate.
    Thomson C; Sobieraj-Teague M; Scott D; Duncan E; Abraham S; Roxby D
    Transfusion; 2021 May; 61(5):1578-1585. PubMed ID: 33728705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.
    Cattaneo M; Simoni L; Gringeri A; Mannucci PM
    Br J Haematol; 1994 Feb; 86(2):333-7. PubMed ID: 8199023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in the fibrinogen and von Willebrand factor content of cryoprecipitate. Implications for reducing donor exposure.
    Hoffman M; Jenner P
    Am J Clin Pathol; 1990 May; 93(5):694-7. PubMed ID: 2327369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
    Hughes C; Thomas KB; Schiff P; Herrington RW; Polacsek EE; McGrath KM
    Transfusion; 1988; 28(6):566-70. PubMed ID: 3143170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
    Cardigan R; Philpot K; Cookson P; Luddington R
    Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
    Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
    Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.